Emerging PET-radiotracers in cardiovascular, neuro-inflammation, lung and rheumatological diseases: a narrative review by Domenico Albano, Alessio Rizzo, Andrea Guarneri, Lucia Leccisotti, Carlo Rodella, Giorgio Treglia

Get full text

The Prevalence and Significance of Incidental Positron Emission Tomography Findings in the Brain Using Radiotracers Other than [¹⁸F]FDG: A Systematic Review and Meta-Ana... by Cesare Michele Iacovitti, Barbara Muoio, Domenico Albano, Alessio Rizzo, Marco Cuzzocrea, Gaetano Paone, Giorgio Treglia

Get full text

Meta-Analysis on the Prevalence and Significance of Incidental Findings in the Thyroid Gland Using Other PET Radiopharmaceuticals Beyond [¹⁸F]FDG by Cesare Michele Iacovitti, Domenico Albano, Alessio Rizzo, Arnoldo Piccardo, Marco Cuzzocrea, Gaetano Paone, Pierpaolo Trimboli, Giorgio Treglia

Get full text

[18F]Tetrafluoroborate, a new NIS PET/CT radiopharmaceutical: an overview focused on differentiated thyroid cancer by Arnoldo Piccardo, Francesco Fiz, Sergio Righi, Stefano Raffa, Mattia Riondato, Gianluca Bottoni, Matteo Bauckneht, Michela Massollo, Alessio Rizzo, Mehrdad Shoushtari Zadeh Naseri, Pierpaolo Trimboli, Giorgio Treglia

Get full text

Diagnostic value of dual-tracer PET/CT with [18F]FDG and PSMA ligands in prostate cancer: an updated systematic review by Cesare Michele Iacovitti, Marco Cuzzocrea, Alessio Rizzo, Matteo Bauckneht, Matteo Bauckneht, Roberto C. Delgado Bolton, Roberto C. Delgado Bolton, Gaetano Paone, Gaetano Paone, Giorgio Treglia, Giorgio Treglia, Giorgio Treglia

Get full text